Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 77 | 2022 | 863 | 8.330 |
Why?
|
| Arthroplasty, Replacement, Knee | 54 | 2023 | 696 | 6.790 |
Why?
|
| Prosthesis-Related Infections | 29 | 2023 | 214 | 5.590 |
Why?
|
| Hip Prosthesis | 45 | 2022 | 605 | 5.370 |
Why?
|
| Prosthesis Failure | 39 | 2021 | 556 | 4.150 |
Why?
|
| Acetabulum | 17 | 2020 | 208 | 3.580 |
Why?
|
| Reoperation | 65 | 2023 | 932 | 3.220 |
Why?
|
| Knee Prosthesis | 21 | 2023 | 248 | 2.790 |
Why?
|
| Femur | 22 | 2019 | 396 | 2.730 |
Why?
|
| Prosthesis Design | 26 | 2022 | 502 | 2.630 |
Why?
|
| Arthritis, Infectious | 7 | 2023 | 59 | 2.030 |
Why?
|
| Knee Joint | 22 | 2022 | 797 | 1.740 |
Why?
|
| Aged | 75 | 2023 | 9448 | 1.690 |
Why?
|
| Osteolysis | 8 | 2015 | 149 | 1.640 |
Why?
|
| Humans | 129 | 2023 | 29337 | 1.610 |
Why?
|
| Anti-Bacterial Agents | 9 | 2023 | 402 | 1.570 |
Why?
|
| Retrospective Studies | 48 | 2023 | 3273 | 1.450 |
Why?
|
| Middle Aged | 69 | 2022 | 9823 | 1.440 |
Why?
|
| Bone Cements | 7 | 2020 | 99 | 1.440 |
Why?
|
| Postoperative Complications | 17 | 2018 | 957 | 1.410 |
Why?
|
| Joint Diseases | 6 | 2021 | 110 | 1.400 |
Why?
|
| Pain, Postoperative | 8 | 2022 | 314 | 1.360 |
Why?
|
| Male | 79 | 2022 | 15621 | 1.360 |
Why?
|
| Hip Joint | 14 | 2020 | 367 | 1.300 |
Why?
|
| Female | 76 | 2022 | 16197 | 1.300 |
Why?
|
| Aged, 80 and over | 46 | 2022 | 4851 | 1.160 |
Why?
|
| Radiography | 21 | 2019 | 678 | 1.070 |
Why?
|
| Periprosthetic Fractures | 6 | 2019 | 32 | 1.040 |
Why?
|
| Tibia | 10 | 2021 | 259 | 0.990 |
Why?
|
| Bone Resorption | 5 | 2014 | 104 | 0.920 |
Why?
|
| Joint Instability | 8 | 2018 | 387 | 0.910 |
Why?
|
| Vancomycin | 3 | 2018 | 57 | 0.900 |
Why?
|
| Hip Dislocation | 9 | 2016 | 65 | 0.890 |
Why?
|
| Pelvic Bones | 3 | 2012 | 20 | 0.800 |
Why?
|
| Treatment Outcome | 34 | 2023 | 3478 | 0.800 |
Why?
|
| Gentamicins | 2 | 2018 | 16 | 0.790 |
Why?
|
| Tobramycin | 2 | 2018 | 9 | 0.790 |
Why?
|
| Leg Length Inequality | 3 | 2016 | 12 | 0.790 |
Why?
|
| Tantalum | 8 | 2018 | 34 | 0.760 |
Why?
|
| Synovial Fluid | 11 | 2017 | 123 | 0.760 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 147 | 0.740 |
Why?
|
| Follow-Up Studies | 20 | 2019 | 1830 | 0.700 |
Why?
|
| Adult | 39 | 2022 | 8601 | 0.660 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 52 | 0.660 |
Why?
|
| Radiostereometric Analysis | 1 | 2018 | 7 | 0.660 |
Why?
|
| Incidence | 9 | 2018 | 756 | 0.650 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 52 | 0.650 |
Why?
|
| Population Surveillance | 2 | 2018 | 116 | 0.640 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 49 | 0.620 |
Why?
|
| Osteotomy | 8 | 2014 | 163 | 0.610 |
Why?
|
| Osseointegration | 7 | 2016 | 76 | 0.610 |
Why?
|
| Surgical Wound Infection | 2 | 2016 | 97 | 0.600 |
Why?
|
| Device Removal | 7 | 2013 | 85 | 0.600 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.570 |
Why?
|
| Bupivacaine | 1 | 2016 | 54 | 0.550 |
Why?
|
| Perioperative Care | 4 | 2017 | 52 | 0.540 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 91 | 0.530 |
Why?
|
| Osteoarthritis, Hip | 4 | 2015 | 94 | 0.530 |
Why?
|
| Metal-on-Metal Joint Prostheses | 2 | 2015 | 57 | 0.530 |
Why?
|
| Risk Factors | 12 | 2019 | 2443 | 0.510 |
Why?
|
| Femur Head | 2 | 2006 | 66 | 0.510 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 124 | 0.510 |
Why?
|
| Metals | 4 | 2015 | 160 | 0.510 |
Why?
|
| Decision Trees | 2 | 2011 | 16 | 0.480 |
Why?
|
| Prospective Studies | 9 | 2019 | 1811 | 0.480 |
Why?
|
| Medical Device Recalls | 1 | 2013 | 3 | 0.470 |
Why?
|
| Polymethyl Methacrylate | 2 | 2011 | 14 | 0.460 |
Why?
|
| Dexamethasone | 1 | 2013 | 48 | 0.460 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2014 | 41 | 0.440 |
Why?
|
| Bacteremia | 1 | 2013 | 115 | 0.440 |
Why?
|
| Fractures, Bone | 3 | 2013 | 73 | 0.430 |
Why?
|
| Poisoning | 1 | 2012 | 3 | 0.430 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 381 | 0.430 |
Why?
|
| Algorithms | 9 | 2022 | 400 | 0.430 |
Why?
|
| Ketamine | 2 | 2022 | 33 | 0.430 |
Why?
|
| Antirheumatic Agents | 3 | 2017 | 92 | 0.420 |
Why?
|
| Patient Readmission | 1 | 2013 | 123 | 0.420 |
Why?
|
| Skin Diseases | 1 | 2012 | 26 | 0.420 |
Why?
|
| Prostheses and Implants | 2 | 2010 | 166 | 0.410 |
Why?
|
| United States | 14 | 2022 | 2333 | 0.390 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 295 | 0.390 |
Why?
|
| Transplantation, Homologous | 7 | 2015 | 277 | 0.390 |
Why?
|
| Orthopedic Surgeons | 2 | 2022 | 27 | 0.380 |
Why?
|
| Biomechanical Phenomena | 8 | 2021 | 668 | 0.370 |
Why?
|
| Iliac Artery | 1 | 2009 | 7 | 0.360 |
Why?
|
| Demography | 3 | 2019 | 77 | 0.350 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 25 | 0.350 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 43 | 0.340 |
Why?
|
| Quality of Life | 2 | 2011 | 662 | 0.340 |
Why?
|
| Recovery of Function | 8 | 2016 | 290 | 0.330 |
Why?
|
| Bone Transplantation | 4 | 2012 | 224 | 0.320 |
Why?
|
| Rheumatology | 3 | 2017 | 81 | 0.320 |
Why?
|
| Patient Discharge | 1 | 2009 | 149 | 0.310 |
Why?
|
| Surgeons | 4 | 2022 | 76 | 0.310 |
Why?
|
| Time Factors | 10 | 2020 | 1616 | 0.300 |
Why?
|
| Arthroplasty | 3 | 2022 | 136 | 0.290 |
Why?
|
| Therapeutic Irrigation | 4 | 2019 | 66 | 0.290 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2011 | 300 | 0.280 |
Why?
|
| Salmonella arizonae | 1 | 2005 | 1 | 0.260 |
Why?
|
| C-Reactive Protein | 7 | 2016 | 125 | 0.260 |
Why?
|
| Cementation | 1 | 2005 | 36 | 0.260 |
Why?
|
| Occupational Diseases | 1 | 2005 | 21 | 0.260 |
Why?
|
| Equipment Failure Analysis | 3 | 2015 | 106 | 0.250 |
Why?
|
| Physical Examination | 4 | 2019 | 117 | 0.240 |
Why?
|
| Risk Assessment | 8 | 2018 | 679 | 0.240 |
Why?
|
| Debridement | 3 | 2013 | 100 | 0.240 |
Why?
|
| Feasibility Studies | 2 | 2018 | 227 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2019 | 230 | 0.230 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2003 | 2 | 0.230 |
Why?
|
| Blood Sedimentation | 8 | 2016 | 64 | 0.230 |
Why?
|
| Cohort Studies | 7 | 2020 | 1939 | 0.220 |
Why?
|
| Pain Measurement | 4 | 2016 | 462 | 0.220 |
Why?
|
| Preoperative Care | 5 | 2016 | 135 | 0.220 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 30 | 0.220 |
Why?
|
| Foreign Bodies | 1 | 2002 | 25 | 0.210 |
Why?
|
| Medicare | 4 | 2013 | 121 | 0.210 |
Why?
|
| Logistic Models | 3 | 2018 | 407 | 0.210 |
Why?
|
| Femoral Neck Fractures | 1 | 2022 | 13 | 0.210 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 114 | 0.210 |
Why?
|
| Porosity | 5 | 2017 | 71 | 0.210 |
Why?
|
| Femoral Fractures | 2 | 2019 | 41 | 0.210 |
Why?
|
| Hemiarthroplasty | 1 | 2022 | 31 | 0.200 |
Why?
|
| Postoperative Period | 3 | 2018 | 288 | 0.200 |
Why?
|
| Case-Control Studies | 2 | 2018 | 638 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 215 | 0.200 |
Why?
|
| Leukocyte Count | 7 | 2016 | 92 | 0.190 |
Why?
|
| Odds Ratio | 2 | 2019 | 285 | 0.190 |
Why?
|
| Bone Nails | 1 | 2020 | 17 | 0.190 |
Why?
|
| Arthrodesis | 1 | 2020 | 40 | 0.190 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2017 | 67 | 0.180 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 9 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 65 | 0.180 |
Why?
|
| Rheumatic Diseases | 2 | 2017 | 56 | 0.180 |
Why?
|
| Illinois | 2 | 2018 | 241 | 0.180 |
Why?
|
| Treatment Failure | 1 | 2019 | 159 | 0.170 |
Why?
|
| Polyethylene | 2 | 2021 | 116 | 0.170 |
Why?
|
| Disease Management | 3 | 2017 | 114 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2019 | 24 | 0.170 |
Why?
|
| Physician Assistants | 1 | 2019 | 18 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 389 | 0.160 |
Why?
|
| Microspheres | 1 | 2018 | 32 | 0.160 |
Why?
|
| Creatinine | 1 | 2018 | 44 | 0.160 |
Why?
|
| Body Mass Index | 5 | 2020 | 428 | 0.160 |
Why?
|
| Absorption, Physiological | 1 | 2017 | 3 | 0.160 |
Why?
|
| Knee | 1 | 2017 | 44 | 0.150 |
Why?
|
| Leukocytes | 1 | 2017 | 43 | 0.150 |
Why?
|
| Range of Motion, Articular | 7 | 2020 | 699 | 0.150 |
Why?
|
| Tendons | 2 | 2012 | 218 | 0.150 |
Why?
|
| Prosthesis Fitting | 3 | 2011 | 22 | 0.150 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 105 | 0.150 |
Why?
|
| Allografts | 2 | 2015 | 180 | 0.150 |
Why?
|
| Regression Analysis | 1 | 2017 | 298 | 0.150 |
Why?
|
| Registries | 3 | 2022 | 188 | 0.150 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 8 | 0.150 |
Why?
|
| Self Concept | 1 | 2016 | 45 | 0.150 |
Why?
|
| Methicillin | 1 | 2016 | 6 | 0.140 |
Why?
|
| Liposomes | 1 | 2016 | 13 | 0.140 |
Why?
|
| Biological Products | 1 | 2017 | 40 | 0.140 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 26 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 132 | 0.140 |
Why?
|
| Orthopedic Procedures | 3 | 2019 | 317 | 0.140 |
Why?
|
| Methicillin Resistance | 1 | 2016 | 31 | 0.140 |
Why?
|
| Nasal Cavity | 1 | 2016 | 35 | 0.140 |
Why?
|
| Kidney | 1 | 2017 | 173 | 0.140 |
Why?
|
| Injections, Intra-Articular | 1 | 2016 | 88 | 0.140 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 85 | 0.140 |
Why?
|
| Chlorhexidine | 1 | 2016 | 61 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2016 | 176 | 0.140 |
Why?
|
| Ceramics | 1 | 2015 | 23 | 0.140 |
Why?
|
| Cell Count | 1 | 2015 | 99 | 0.140 |
Why?
|
| Prevalence | 3 | 2013 | 487 | 0.140 |
Why?
|
| Patella | 2 | 2015 | 81 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 148 | 0.130 |
Why?
|
| Foreign-Body Reaction | 1 | 2015 | 32 | 0.130 |
Why?
|
| Nerve Block | 1 | 2016 | 62 | 0.130 |
Why?
|
| Sensitivity and Specificity | 6 | 2015 | 553 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 162 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 333 | 0.130 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 68 | 0.120 |
Why?
|
| Bone Diseases | 2 | 2005 | 24 | 0.120 |
Why?
|
| Length of Stay | 2 | 2013 | 317 | 0.120 |
Why?
|
| Sleep | 1 | 2017 | 313 | 0.120 |
Why?
|
| Observer Variation | 1 | 2014 | 118 | 0.120 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2013 | 18 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2013 | 22 | 0.120 |
Why?
|
| Awards and Prizes | 1 | 2013 | 24 | 0.120 |
Why?
|
| Decision Making | 2 | 2006 | 220 | 0.120 |
Why?
|
| Random Allocation | 1 | 2013 | 146 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 37 | 0.110 |
Why?
|
| Bone Remodeling | 1 | 2013 | 44 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2019 | 1184 | 0.110 |
Why?
|
| Tibial Fractures | 1 | 2012 | 13 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 100 | 0.110 |
Why?
|
| ROC Curve | 4 | 2016 | 138 | 0.110 |
Why?
|
| Heavy Metal Poisoning | 1 | 2012 | 2 | 0.110 |
Why?
|
| Braces | 1 | 2012 | 26 | 0.110 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 13 | 0.110 |
Why?
|
| Serologic Tests | 1 | 2011 | 15 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 521 | 0.090 |
Why?
|
| Suction | 3 | 2015 | 41 | 0.090 |
Why?
|
| Corrosion | 3 | 2015 | 139 | 0.090 |
Why?
|
| Pain Management | 2 | 2022 | 143 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 194 | 0.090 |
Why?
|
| Infection Control | 1 | 2011 | 169 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 24 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2017 | 358 | 0.090 |
Why?
|
| Sepsis | 1 | 2010 | 144 | 0.080 |
Why?
|
| Anesthesia | 1 | 2009 | 34 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2009 | 75 | 0.080 |
Why?
|
| Preoperative Period | 2 | 2020 | 65 | 0.080 |
Why?
|
| Body Weight | 2 | 2019 | 133 | 0.080 |
Why?
|
| Hip Fractures | 1 | 2008 | 32 | 0.080 |
Why?
|
| Arthritis, Juvenile | 2 | 2017 | 8 | 0.080 |
Why?
|
| Pyrimidines | 2 | 2017 | 21 | 0.080 |
Why?
|
| Pyrroles | 2 | 2017 | 17 | 0.080 |
Why?
|
| Piperidines | 2 | 2017 | 32 | 0.080 |
Why?
|
| Arthritis, Psoriatic | 2 | 2017 | 17 | 0.080 |
Why?
|
| Linear Models | 2 | 2018 | 254 | 0.080 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2017 | 44 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2009 | 140 | 0.080 |
Why?
|
| Biomarkers | 3 | 2017 | 689 | 0.070 |
Why?
|
| Age Distribution | 2 | 2005 | 94 | 0.070 |
Why?
|
| Chicago | 3 | 2018 | 865 | 0.070 |
Why?
|
| Sex Distribution | 2 | 2005 | 87 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2020 | 495 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 10 | 0.070 |
Why?
|
| Joint Dislocations | 2 | 2018 | 57 | 0.070 |
Why?
|
| Southeastern United States | 1 | 2006 | 9 | 0.070 |
Why?
|
| Surface Properties | 1 | 2006 | 144 | 0.070 |
Why?
|
| Contraindications | 1 | 2006 | 41 | 0.070 |
Why?
|
| Neutrophils | 2 | 2017 | 117 | 0.070 |
Why?
|
| Ankle Injuries | 1 | 2005 | 12 | 0.070 |
Why?
|
| Salmonella Infections | 1 | 2005 | 3 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2005 | 96 | 0.070 |
Why?
|
| Markov Chains | 1 | 2005 | 29 | 0.070 |
Why?
|
| Animal Husbandry | 1 | 2005 | 6 | 0.070 |
Why?
|
| Swine | 1 | 2005 | 80 | 0.060 |
Why?
|
| Graft Survival | 1 | 2005 | 98 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 1113 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2017 | 202 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2005 | 132 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 330 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2005 | 78 | 0.060 |
Why?
|
| Chromium | 2 | 2015 | 92 | 0.060 |
Why?
|
| Cobalt | 2 | 2015 | 116 | 0.060 |
Why?
|
| Titanium | 2 | 2015 | 209 | 0.060 |
Why?
|
| Tendon Injuries | 1 | 2005 | 196 | 0.060 |
Why?
|
| Hospitalization | 1 | 2005 | 317 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 145 | 0.050 |
Why?
|
| Polyethylenes | 1 | 2002 | 50 | 0.050 |
Why?
|
| Animals | 3 | 2007 | 4552 | 0.050 |
Why?
|
| Young Adult | 3 | 2014 | 1932 | 0.050 |
Why?
|
| Analgesics | 1 | 2022 | 108 | 0.050 |
Why?
|
| Machine Learning | 1 | 2022 | 54 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 144 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 498 | 0.050 |
Why?
|
| Social Class | 1 | 2021 | 64 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2003 | 642 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 138 | 0.050 |
Why?
|
| Recurrence | 2 | 2011 | 350 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2020 | 60 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2020 | 140 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 100 | 0.050 |
Why?
|
| Survivorship | 1 | 2019 | 17 | 0.040 |
Why?
|
| Arthritis | 1 | 2020 | 107 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 1 | 2019 | 71 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 391 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2003 | 363 | 0.040 |
Why?
|
| Patient Selection | 2 | 2012 | 232 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 33 | 0.040 |
Why?
|
| Child | 1 | 2003 | 1346 | 0.040 |
Why?
|
| Forecasting | 1 | 2018 | 117 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 175 | 0.040 |
Why?
|
| Spondylarthritis | 1 | 2017 | 5 | 0.040 |
Why?
|
| Cost Savings | 1 | 2017 | 36 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 47 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 340 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 496 | 0.040 |
Why?
|
| Adolescent | 1 | 2003 | 2279 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2015 | 29 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 190 | 0.030 |
Why?
|
| Orthopedics | 1 | 2017 | 127 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 97 | 0.030 |
Why?
|
| Geography | 2 | 2005 | 22 | 0.030 |
Why?
|
| Patellar Ligament | 1 | 2015 | 52 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 66 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 80 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 65 | 0.030 |
Why?
|
| Anthropometry | 1 | 2012 | 37 | 0.030 |
Why?
|
| California | 1 | 2012 | 31 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 13 | 0.030 |
Why?
|
| Fees and Charges | 1 | 2012 | 7 | 0.030 |
Why?
|
| Causality | 1 | 2011 | 53 | 0.030 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 9 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 788 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 36 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 11 | 0.020 |
Why?
|
| Arthralgia | 1 | 2012 | 121 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 226 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 295 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 38 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 843 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 840 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2010 | 116 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2008 | 44 | 0.020 |
Why?
|
| Fracture Healing | 1 | 2008 | 40 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 25 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1221 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 137 | 0.020 |
Why?
|
| Research | 1 | 2006 | 54 | 0.020 |
Why?
|
| Medicare Part B | 1 | 2005 | 1 | 0.020 |
Why?
|
| Health Services for the Aged | 1 | 2005 | 10 | 0.020 |
Why?
|
| Equipment Design | 1 | 2006 | 185 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 252 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 324 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1442 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 101 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 349 | 0.010 |
Why?
|